Benzinga
Benzinga
Benzinga
domenica, settembre 27

Connect Biopharma Holdings Ltd

CNTBNASDAQ
Trade with Public
Trade with Public
$1.08
-0.02-1.82%
In chiusura: Sep 25, 5:00 PM EST
$1.09
0.010.93%
Post-mercato: Sep 25, 7:24 PM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Connect Biopharma Hldgs Analyst Price Targets

Wall Street analyst price targets and consensus rating for Connect Biopharma Hldgs (CNTB).

Price Target Range — 10 Quarters

Analyst Consensus — 7 Analysts

7Buy
Consensus RatingBuy# Analysts7Avg. Consensus PT$7Upside to Avg. PT+542.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
Sep 22, 2026OppenheimerMazahir AlimohamedPT CutOutperform$8→$5
Sep 17, 2026HC Wainwright & Co.Brandon FolkesMaintainedBuy$7
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Oppenheimer Maintains Outperform on Connect Biopharma Hldgs, Lowers Price Target to $5

Oppenheimer analyst Mazahir Alimohamed maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Outperform and lowers the price target from $8 to $5.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Connect Biopharma Hldgs, Maintains $7 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Connect Biopharma Hldgs, Lowers Price Target to $6

Canaccord Genuity analyst Edward Nash maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and lowers the price target from $7 to $6.
Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Connect Biopharma Hldgs, Maintains $10 Price Target

BTIG analyst Julian Harrison reiterates Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and maintains $10 price target.
Benzinga Newsdesk

PRO
Oppenheimer Initiates Coverage On Connect Biopharma Hldgs with Outperform Rating, Announces Price Target of $8

Oppenheimer analyst Mazahir Alimohamed initiates coverage on Connect Biopharma Hldgs (NASDAQ:CNTB) with a Outperform rating and announces Price Target of $8.
Benzinga Newsdesk

PRO
Piper Sandler Initiates Coverage On Connect Biopharma Hldgs with Overweight Rating, Announces Price Target of $7

Piper Sandler analyst Biren Amin initiates coverage on Connect Biopharma Hldgs (NASDAQ:CNTB) with a Overweight rating and announces Price Target of $7.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved